Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Treat to target in weight management with semaglutide: Real-world evidence from an eHealth clinic
Development of GLP-1MK-801 To safely harness the weight-lowering properties of NMDA receptor antagonism, we developed a targeting approach based on the hypothesis that conjugation of MK-801 to a GLP-1 analogue through a chemically cleavable disulfide linker would enhance the therapeutic potential of NMDA receptor antagonism in appetite-regulating brain regions enriched for GLP-1 receptors, while mitigating the adverse effects related to the non-restricted actions of MK-801
Xenosteroids in aquaculture with special consideration to Lake Manzala (Northern delta lake, Egypt): types, sources and mechanism of action
clinical trial data
US$ 21.31
US$ 25.89
US$ 22.06
US$ 25.89
US$ 26.92
US$ 25.99
US$ 26.50
US$ 24.20
